Luca Benatti is Director at INTERCEPT PHARMACEUTICALS, INC. (ICPT). They have made 3 open-market trades across 2 companies since 2014, most recently 2025-12-26.
2 open-market purchases totalling $212K since 2014, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| QNCX | 89,179 | $2.8M |
| ICPT | 33,598 | $638K |
| Total | $3.4M |
Shares reported on the most recent Form 4, priced at the 2025-12-29 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.